|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08156 SINOPHARM TECH
Nominal 
0.213 0.000 (0.000%) | 2026/06 - Final HKD(K$) | %Chg (Compare to Final) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | |
| Turnover | 45,582 | -25.584% | 61,253 | 41,277 | 42,839 | 40,985 |
| Cost of Sales | (39,161) | -16.718% | (47,022) | (36,258) | (37,369) | (35,053) |
| Gross Profit | 6,421 | -54.880% | 14,231 | 5,019 | 5,470 | 5,932 |
| 2026/06 - Final HKD(K$) | %Chg (Compare to Final) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | 1,060 | (2,734) | 1,815 | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | (19,217) | -- | |
| Other Non-operating Items | -- | -- | -- | -- | (1,131) | (21,889) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 186 | (153) | |
| Profit / (Loss) before Taxation | (11,690) | 983.411% | (1,079) | (20,332) | (11,407) | (94,158) | |
| Taxation | (213) | -26.804% | (291) | (83) | 1,307 | 387 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | 388 | -- | -- | |
| Non-controlling Interests | 2,761 | 448.907% | 503 | 329 | (535) | 5,773 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (9,142) | 954.441% | (867) | (19,698) | (10,635) | (87,998) | |
| 2026/06 - Final HKD(K$) | %Chg (Compare to Final) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | |
| Net Finance Costs / (Income) | 4,006 | -31.533% | 5,851 | 23,849 | 8,569 | 16,407 |
| Depreciation & Amortisation | 1,228 | -7.877% | 1,333 | 1,378 | 2,007 | 2,426 |
| Directors' Emoluments | 1,122 | -54.593% | 2,471 | 2,637 | 4,248 | 8,742 |
| 2026/06 - Final | %Chg (Compare to Final) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | Unqualified (Modified Report) | -- | Qualified | Qualified | Qualified | Qualified |
Market Valuation Indicators
| 2026/06 - Final | %Chg (Compare to Final) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | -1.970 | 936.842% | -0.190 | -10.720 | -0.060 | -49.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.009) | -- | (0.012) | (0.050) | 0.026 | (0.204) |
| NBV per share ($) | (0.073) | -- | (0.058) | (1.086) | (0.940) | (0.919) |
| Remarks: | Real time quote last updated: 07/10/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -9,142 |
| %Change | 954.441% |
| EPS / (LPS) | HKD -0.020 |
| NBV Per Share ($) | HKD -0.073 |